Evidence map›Paper›PMID 25675302›Full record

ArticleCell death & disease2015

Mitochondrial Lon regulates apoptosis through the association with Hsp60-mtHsp70 complex.

T-Y Kao, Y-C Chiu, W-C Fang, C-W Cheng, C-Y Kuo, H-F Juan, S-H Wu, A Y-L Lee

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 80 citations in OpenAlex.

  1. Review
  2. Review
  3. Molecular mechanisms of mitochondrial AAA+ proteases.The Journal of biological chemistry · 2026
    Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Research progress on mitochondria regulating tumor immunity.Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2024
    Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

T-Y KaoDepartment of Medical Laboratory Science and Biotechnology, Yuanpei University, Hsinchu 300, Taiwan.
Y-C Chiu1] Department of Medical Laboratory Science and Biotechnology, Yuanpei University, Hsinchu 300, Taiwan [2] National Institute of Cancer Research, National Health Research Institutes, Zhunan, Miaoli 35053, Taiwan.
W-C Fang1] National Institute of Cancer Research, National Health Research Institutes, Zhunan, Miaoli 35053, Taiwan [2] Institute of Biological Chemistry, Academia Sinica, Taipei 115, Taiwan [3] Institute of Biochemical Sciences, National Taiwan University, Taipei 106, Taiwan.
C-W ChengNational Institute of Cancer Research, National Health Research Institutes, Zhunan, Miaoli 35053, Taiwan.
C-Y KuoNational Institute of Cancer Research, National Health Research Institutes, Zhunan, Miaoli 35053, Taiwan.
H-F Juan1] Institute of Molecular and Cellular Biology, National Taiwan University, Taipei 106, Taiwan [2] Department of Life Science, National Taiwan University, Taipei 106, Taiwan.
S-H Wu1] Institute of Biological Chemistry, Academia Sinica, Taipei 115, Taiwan [2] Institute of Biochemical Sciences, National Taiwan University, Taipei 106, Taiwan [3] Department of Chemistry, National Taiwan University, Taipei 106, Taiwan.
A Y-L Lee1] National Institute of Cancer Research, National Health Research Institutes, Zhunan, Miaoli 35053, Taiwan [2] Graduate Institute of Basic Medical Science, China Medical University, Taichung 404, Taiwan.
National Health Research Institutes · TWYuanpei University · TWInstitute of Biological Chemistry, Academia Sinica · TWNational Taiwan University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human Lon protease is a mitochondrial matrix protein with several functions, including protein degradation, mitochondrial DNA (mtDNA) binding, and chaperone activity. Lon is currently emerging as an important regulator of mitochondria-contributed tumorigenesis due to its overexpression in cancer cells. To understand the mechanism of increased Lon in tumor cells, we studied the interactome to identify the chaperone Lon-associated proteins by proteomics approaches using the cells overexpressing Lon. In the present study, we designed a method connecting co-immunoprecipitation (Co-IP) to in-solution digestion for the shotgun mass spectrometry. We identified 76 proteins that were putative Lon-associated proteins that participated in mitochondrial chaperone system, cellular metabolism and energy, cell death and survival, and mtDNA stability. The association between Lon and NDUFS8 or Hsp60-mtHsp70 complex was confirmed by Co-IP and immunofluorescence co-localization assay. We then found that the protein stability/level of Hsp60-mtHsp70 complex depends on the level of Lon under oxidative stress. Most importantly, the ability of increased Lon-inhibited apoptosis is dependent on Hsp60 that binds p53 to inhibit apoptosis. These results suggest that the mechanism underlying cell survival regulated by Lon is mediated by the maintenance of the protein stability of Hsp60-mtHsp70 complex. This new knowledge of chaperone Lon interactome will allow us to better understand the cellular mechanism of Lon in mitochondrial function and of its overexpression in enhancing cell survival and tumorigenesis.

Indexed as

ApoptosisBlotting, WesternCell LineCell SurvivalChaperonin 60Computational BiologyHSP70 Heat-Shock ProteinsHumansImmunoprecipitationMitochondriaProtease LaProtein BindingTandem Mass SpectrometryChaperonin 60HSP70 Heat-Shock ProteinsProtease La

Identifiers

PMID25675302
PMCPMC4669791
OpenAlexW2033552465

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.